Sanai Health Industry Group Valuation

Q: What is the Fair Price of WUP0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

WUP0 (€0.03) is trading below our estimate of [[fair value]] (€35.52)

Is WUP0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of WUP0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: WUP0 (€0.03) is trading below our estimate of fair value (€35.52)

Significantly Below Fair Value: WUP0 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for WUP0?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for WUP0. This is calculated by dividing WUP0's market cap by their current preferred multiple.
What is WUP0's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥45.21m

WUP0 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does WUP0's PE Ratio compare to its peers?

The above table shows the PE ratio for WUP0 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	21.1x
B8FK Biofrontera	37.9x	n/a	€15.1m
2FJ0 Pierrel	29.9x	n/a	€92.8m
93M1 MPH Health Care	2.7x	8.4%	€77.1m
PSG PharmaSGP Holding	13.9x	12.3%	€249.4m
WUP0 Sanai Health Industry Group	2.4x	n/a	€49.7m

Price-To-Earnings vs Peers: WUP0 is good value based on its Price-To-Earnings Ratio (2.4x) compared to the peer average (20.9x).

Price to Earnings Ratio vs Industry

How does WUP0's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: WUP0 is good value based on its Price-To-Earnings Ratio (2.4x) compared to the European Pharmaceuticals industry average (23x).

Price to Earnings Ratio vs Fair Ratio

What is WUP0's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WUP0 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	2.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate WUP0's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.